ChargePoint announces key leadership appointments. Mansi Khetani has been appointed Chief Financial Officer, effective July 9, 2024. Khetani has been with ChargePoint since 2018, previously leading Financial Planning and Analysis efforts before becoming interim CFO in November 2023.

Pfizer advances its once-daily modified release formulation for danuglipron, an oral GLP-1 receptor agonist, after positive Phase 1 pharmacokinetic study results. Dose optimization studies will follow in H2 2024, aiming to enhance obesity treatment options.

E2open Parent Holdings reports Q1 FY25 results with revenue decline and in-line adjusted EPS. Q2 outlook is $129M-$132M for GAAP Subscription revenue and FY25 outlook is $630M-$645M for revenue and $532M-$542M for subscription revenue.

FuelCell said its technology is now deployed across South Korea producing more than 100 megawatts of sustainable electricity without combusting fuel. The company is committed to working with Korea on its Hydrogen Economy Roadmap, which aims to supply 15 gigawatts of power from fuel cells by 2040.